| Literature DB >> 27335863 |
Tanja Mols-Vorstermans1, Andrew Hemphill2, Thierry Monney2, Dick Schaap1, Eveline Boerhout1.
Abstract
C57BL/6, BALB/c, and CBA/Ca mouse strains with different MHC-I haplotypes were compared with respect to susceptibility to Neospora caninum infection. Groups of 5 mice received 1 × 10(6), 5 × 10(6), or 25 × 10(6) tachyzoites of the NC-Liverpool isolate by intraperitoneal injection and were observed for disease symptoms. Humoral responses, splenocyte interferon-γ (IFN-γ) production, cerebral parasite loads, and histopathology were evaluated at human end points or the latest at 34 days postinfection (PI). The mortality rates in C57BL/6 mice were the highest, and relatively high levels of IgG1 antibodies were detected in those mice surviving till 34 days PI. In lymphocyte proliferation assays, spleen cells from C57BL6 mice stimulated with N. caninum antigen extract exhibited large variations in IFN-γ production. In BALB/c mice mortality was 0% at the lowest and 100% at the highest infection dose. Serologically they responded with high levels of both IgG2a and IgG1 subclasses, and lymphocyte proliferation assays of surviving mice yielded lower IFN-γ levels. CBA/Ca mice were the most resistant, with no animal succumbing to infection at a dose of 1 × 10(6) and 5 × 10(6) tachyzoites, but 100% mortality at 25 × 10(6) tachyzoites. High IgG2a levels as well as increased IFN-γ in lymphocyte proliferation assays were measured in CBA/Ca mice infected with 1 × 10(6) tachyzoites.Entities:
Year: 2013 PMID: 27335863 PMCID: PMC4890932 DOI: 10.5402/2013/830980
Source DB: PubMed Journal: ISRN Parasitol ISSN: 2314-4076
Figure 1Mean group morbidity scores ((a), (c), and (e)) and mean weight changes ((b), (d), and (f)) in BALB/c, CBA/Ca, and C57BL/6 mice following i.p. inoculation with 1 × 106, 5 × 106, or 25 × 106 NC-Liv tachyzoites. Mice were scored for clinical symptoms including hunched back, ruffled hair coat, impaired movement, and spinning when picked up by the tail, resulting in a maximum clinical score per mouse of 4. Figures 1(a), 1(c), and 1(e) show the average clinical score per mice per group. ∗indicate the death of a mouse; error bars ± SD; n = 5.
Figure 2Survival plot of mice 34 days after challenge with NC-Liv tachyzoites.
Experimental groups, numbers of symptomatic mice, and numbers of parasites in brain and brain lesion scores at the time of death or euthanasia (intercurrent death) or at the end of the experiment at day 34 PI. The detection limit of the PCR is 10 parasites/reaction. Lesions were graded using the following system: (0) no lesions, (1) light positive or small foci, (2) moderately positive, (3) severely positive with large inflammatory process, ∗tachyzoites, and ∗∗cyst.
| Experimental groups ( | Number of symptomatic mice | Time of death (day PI) | Number of parasites in 20 ng brain DNA (real-time PCR) | Brain lesion score (histopathology) | |
|---|---|---|---|---|---|
| 1 × 106 | 0 | 34, 34, 34, 34, 34 | 0, 0, 0, 361, 300 | 0, 0, 0, 1, 0 | |
| BALB/c | 5 × 106 | 5 | 34, 34, 34, 34, 23 | 464, 651, 488, 902, 1183 | 0, 2, 1, 1, 2 |
| 25 × 106 | 5 | 8, 12, 8, 12, 7 | 587, 763, 260, ND, 154 | 0, 0, 0, 0, 0 | |
|
| |||||
| 1 × 106 | 0 | 34, 34, 34, 34, 34 | 0, 0, 0, 0, 156 | 3∗, 0, 0, 2, 0 | |
| CBA/Ca | 5 × 106 | 0 | 34, 34, 34, 34, 34 | 0, 0, 0, 0, 0 | 0, 0, 0, 0, 0 |
| 25 × 106 | 5 | 9, 9, 8, 9, 9 | 466, 433, 349, 606, 593 | 0, 0, 1, 1, 2 | |
|
| |||||
| 1 × 106 | 2 | 34, 34, 29, 29, 34 | 0, 177, 525, 0, 763 | 0, 0, 1, 1, 2 | |
| C57BL/6 | 5 × 106 | 5 | 13, 7, 34, 8, 34 | 312, 0, 638, 0, 879 | 3∗∗, 0, 2, 0, 3 |
| 25 × 106 | 5 | 8, 8, 34, 8, 8 | 344, 325, 788, 232, 0 | 0, 0, 2, 0, 0 | |
IgG2a or IgG2c and IgG1 titres were measured at the time of death or euthanasia (intercurrent death) or at the end of the experiment at day 34 PI. For calculation, the value “4.5” was chosen when the titre was below the detection limit (<5.0).
| Experimental groups | Antibodies at day 34 or time of euthanization (2log) | |||||
|---|---|---|---|---|---|---|
| Mouse number | Survival time (days) | |||||
| Inbred strain | Challenge dose | IgG2a/c | IgG1 | IgG2a/c-IgG1 | ||
| 1.1 | 34 | 13.6 | 11.2 | 2.4 | ||
| 1.2 | 34 | 14.1 | 11.0 | 3.1 | ||
| BALB/c | 1 × 106 | 1.3 | 34 | 13.0 | 11.6 | 1.4 |
| 1.4 | 34 | 14.1 | 14.4 | −0.3 | ||
| 1.5 | 34 | 14.7 | 15.4 | −0.7 | ||
|
| ||||||
| 2.1 | 34 | 14.6 | 14.6 | 0.0 | ||
| 2.2 | 34 | 14.8 | 15.8 | −1.0 | ||
| BALB/c | 5 × 106 | 2.3 | 34 | 14.5 | 14.7 | −0.2 |
| 2.4 | 23 | 14.4 | 13.3 | 1.1 | ||
| 2.5 | 23 | 15.0 | 14.0 | 1.0 | ||
|
| ||||||
| 3.1 | 8 | — | — | — | ||
| 3.2 | 12 | — | — | — | ||
| BALB/c | 25 × 106 | 3.3 | 8 | 9.9 | 7.7 | 2.2 |
| 3.4 | 12 | 9.4 | 8.3 | 1.1 | ||
| 3.5 | 7 | — | — | — | ||
|
| ||||||
| 4.1 | 34 | 10.8 | 4.5 | 6.3 | ||
| 4.2 | 34 | 14.8 | 6.5 | 8.3 | ||
| CBA/Ca | 1 × 106 | 4.3 | 34 | 11.0 | 6.7 | 4.3 |
| 4.4 | 34 | 11.2 | 4.5 | 6.7 | ||
| 4.5 | 34 | 13.9 | 9.8 | 4.1 | ||
|
| ||||||
| 5.1 | 34 | 12.2 | 6.0 | 6.2 | ||
| 5.2 | 34 | 13.1 | 5.1 | 8.0 | ||
| CBA/Ca | 5 × 106 | 5.3 | 34 | 13.3 | 9.2 | 4.1 |
| 5.4 | 34 | 13.5 | 9.6 | 3.9 | ||
| 5.5 | 34 | 13.6 | 12.2 | 1.4 | ||
|
| ||||||
| 6.1 | 9 | 5.0 | 4.5 | 0.5 | ||
| 6.2 | 9 | 6.0 | 6.9 | −0.9 | ||
| CBA/Ca | 25 × 106 | 6.3 | 8 | — | — | — |
| 6.4 | 9 | 5.7 | 4.5 | 1.2 | ||
| 6.5 | 9 | 4.5 | 4.5 | 0.0 | ||
|
| ||||||
| 7.1 | 34 | 13.4 | 9.8 | 3.6 | ||
| 7.2 | 34 | 14.9 | 14.6 | 0.3 | ||
| C57BL/6 | 1 × 106 | 7.3 | 29 | 14.1 | 10.8 | 3.3 |
| 7.4 | 29 | 12.9 | 7.1 | 5.8 | ||
| 7.5 | 34 | 14.6 | 9.2 | 5.4 | ||
|
| ||||||
| 8.1 | 13 | 10.1 | 4.5 | 5.6 | ||
| 8.2 | 7 | 4.5 | 4.5 | 0.0 | ||
| C57BL6 | 5 × 106 | 8.3 | 34 | 15.6 | 13.4 | 2.2 |
| 8.4 | 8 | 10.5 | 4.5 | 6.0 | ||
| 8.5 | 34 | 16.5 | 13.7 | 2.8 | ||
|
| ||||||
| 9.1 | 8 | 10.7 | 6.9 | 3.8 | ||
| 9.2 | 8 | 7.4 | 4.5 | 2.9 | ||
| C57BL6 | 25 × 106 | 9.3 | 34 | 15.6 | 14.5 | 1.1 |
| 9.4 | 8 | 7.7 | 4.5 | 3.2 | ||
| 9.5 | 8 | 8.5 | 4.5 | 4.0 | ||
Figure 4Difference between IgG2a or IgG2c and IgG1 levels in postinfection sera. (a) Infection dose of 1 × 106 tachyzoites. (b) Infection dose of 5 × 106 tachyzoites. ∗Indicates a statistically significant difference between the groups (P < 0.05). ∗∗Indicates a highly significant difference between the groups (P < 0.01).
Figure 3IFN-γ production by stimulated splenocytes derived from BALB/c, CBA/Ca, and C57BL/6 mice challenged with varying doses of Nc-Liv tachyzoites. The IFN-γ production was analyzed in triplicates. Results show the mean values ± SD.